Melanotan I 10 mg, glass vial, crimp seal, flip-top cap, California Standard Peptides label

Research peptides

Melanotan I

Melanotan I is the earlier name for afamelanotide, [Nle4, D-Phe7]-alpha-MSH, a synthetic 13-amino-acid analogue of alpha-melanocyte-stimulating hormone that was first synthesized in 1980.

10 mgCS-MT1-10$55.00
Choose a size and add to cart →
Container
Glass vial, crimp seal, flip-top cap
Storage
-20 °C, desiccated
Paperwork
Lot certificate (HPLC + mass spec) shown before you pay

Lot certificates

You’ll see American Peptides on the lab’s copy. They’re our supplier.

  • 10 mg, lot MT110-0318: 99.80% purity (RP-HPLC), 10.78 mg measured, identity confirmed by mass spec. Issued 2026-04-03 by Bioviridian Inc.. Verify certificate COA3394

Our vials are filled from lots made by our supplier, American Peptides, and tested by Bioviridian Inc.The laboratory’s original certificate lists American Peptides as the vendor. Look up the code at bioviridians.com to check it.

What researchers study it for

  • Erythropoietic protoporphyria
  • Skin pigmentation and eumelanin
  • Vitiligo
  • Polymorphic light eruption and solar urticaria

How it is thought to work

Afamelanotide is a melanocortin receptor agonist that binds predominantly to the melanocortin-1 receptor. Receptor signaling increases production of eumelanin in the skin, independently of exposure to sunlight or artificial UV light. This mechanism is well established and is described in the FDA label.

Where the research stands

Approved drug (as afamelanotide, Scenesse). Afamelanotide is approved in the EU (2014) and the USA (2019) for adults with erythropoietic protoporphyria, supported by randomized, placebo-controlled trials. That approval applies to the licensed product only.

Sources

  1. Langendonk JG, et al. (2015). Afamelanotide for Erythropoietic Protoporphyria. The New England Journal of Medicine.
  2. Dorr RT, et al. (2000). Increased eumelanin expression and tanning is induced by a superpotent melanotropin [Nle4-D-Phe7]-alpha-MSH in humans. Photochemistry and Photobiology.
  3. Minder EI, et al. (2017). Pharmacokinetics and Pharmacodynamics of Afamelanotide and its Clinical Use in Treating Dermatologic Disorders. Clinical Pharmacokinetics.
  4. Wu J, Cotliar R. (2021). Afamelanotide: An Orphan Drug with Potential for Broad Dermatologic Applications. Journal of Drugs in Dermatology.

For laboratory research use only. Not a drug, food, supplement or cosmetic; not for human or veterinary use. Nothing on this page is medical advice or a usage guide.

California Standard Peptides

Your cart

0 items · free shipping over $200.00

Your cart is empty.

Buy 2 of a vial and save 10%, 3 and save 15%. Research sets are 15% off, and shipping is free over $200.00.

First order

20% off your first order.

Join the list for first word on new lots, restocks and member pricing. Your code arrives by email and applies by itself at checkout.

One code per email, for your first order. By signing up you agree to get emails from us. Unsubscribe anytime.

For laboratory research use only. 21+.